280 related articles for article (PubMed ID: 6754634)
1. The hypotensive effect of a single daily dose of labetalol: a preliminary study.
Rossi A; Ziacchi V; Lomanto B
Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):438-45. PubMed ID: 6754634
[TBL] [Abstract][Full Text] [Related]
2. Experience with labetalol in hypertension.
Bolli P; Waal-Manning J; Wood AJ; Simpson FO
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):765-71. PubMed ID: 791330
[TBL] [Abstract][Full Text] [Related]
3. Labetalol in resistant hypertension.
Dargie HJ; Dollery CT; Daniel J
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):751-5. PubMed ID: 990154
[TBL] [Abstract][Full Text] [Related]
4. Double-blind trial of labetalol.
Kane J; Gregg I; Richards DA
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
[TBL] [Abstract][Full Text] [Related]
5. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
Pugsley DJ; Armstrong BK; Nassim MA; Beilin LJ
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):777-82. PubMed ID: 791331
[TBL] [Abstract][Full Text] [Related]
6. Acute management of severe hypertension with oral labetalol.
Ghose RR
Br J Clin Pharmacol; 1979; 8(Suppl 2):189S-193S. PubMed ID: 526400
[TBL] [Abstract][Full Text] [Related]
7. Labetalol and pindolol in the treatment of hypertension: a comparative study.
Romo M; Halttunen P; Saarinen P; Sarna S
Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
[TBL] [Abstract][Full Text] [Related]
8. A multicentre study of labetalol in hypertension. New Zealand Hypertension Study Group.
N Z Med J; 1981 Apr; 93(681):215-8. PubMed ID: 7017511
[TBL] [Abstract][Full Text] [Related]
9. A controlled comparison of the antihypertensive effects of labetalol and alpha-methyldopa.
Al-Damluji SF; Al-Khalidi A; Shaarbaf H; Tawfiq NH
Pharmatherapeutica; 1982; 3(2):133-9. PubMed ID: 7048338
[TBL] [Abstract][Full Text] [Related]
10. A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
Pandhi P; Aslam S; Sharma BK; Sharma PL; Wahi PL
Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):101-4. PubMed ID: 3886563
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of methyldopa and labetalol in the treatment of hypertension.
Sanders GL; Davies DM; Gales GM; Rao JG; Rawlins MD; Routledge PA
Br J Clin Pharmacol; 1979; 8(Suppl 2):149S-151S. PubMed ID: 393286
[TBL] [Abstract][Full Text] [Related]
12. The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension.
la Cour Petersen E; Kristensen BO
Postgrad Med J; 1980; 56 Suppl 2():60-4. PubMed ID: 7433345
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of hypertension with labetalol.
Erichs M; Rothgardt NP; Andersson E
Postgrad Med J; 1980; 56 Suppl 2():53-6. PubMed ID: 7433343
[TBL] [Abstract][Full Text] [Related]
14. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
Thompson FD; Joekes AM; Hussein MM
Br J Clin Pharmacol; 1979; 8(Suppl 2):129S-133S. PubMed ID: 526392
[TBL] [Abstract][Full Text] [Related]
15. [Labetalol in the treatment of arterial hypertension. A Brazilian multicenter study].
Benchimol AB; Sbissa AS; Benchimol CB; Saad EA; Barbosa ET; Albanesi Filho FM; Pillegi F; da Cunha GP; Maranhão MF; Batlouni M; Schlesinger P; Duprat R; Maciel R
Arq Bras Cardiol; 1982 May; 38(5):421-7. PubMed ID: 6762868
[No Abstract] [Full Text] [Related]
16. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
Hauger-Klevene JH
Pharmatherapeutica; 1981; 3(1):46-54. PubMed ID: 7033992
[TBL] [Abstract][Full Text] [Related]
17. A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension.
Chalmers AG; Hunter J; Lees CD; Millar JA; Brown JJ; Robertson JI
Br J Clin Pharmacol; 1979; 8(Suppl 2):183S-187S. PubMed ID: 526399
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hypertension with labetalol.
Bolli P; Waal-Manning HJ; Simpson FO; Seeman HM
N Z Med J; 1977 Dec; 86(602):557-63. PubMed ID: 306082
[TBL] [Abstract][Full Text] [Related]
19. Labetalol in severe and resistant hypertension.
Williams LC; Murphy MJ; Parsons V
Br J Clin Pharmacol; 1979; 8(Suppl 2):143S-147S. PubMed ID: 526395
[TBL] [Abstract][Full Text] [Related]
20. A multicentre open trial of labetalol in New Zealand.
Br J Clin Pharmacol; 1979; 8(Suppl 2):179S-182S. PubMed ID: 393287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
